India’s intellectual property (IP) landscape is undergoing a subtle yet significant transformation. Various government bodies have introduced concept notes, circulars, and guidelines aimed at protecting 'innovation', fostering a 'level playing field', and aligning domestic laws with 'global standards'. However, these initiatives have sparked debate over the appropriateness and evidentiary basis of expanding IP protections.
A foundational principle in copyright law is that it safeguards authorial expression but not the underlying ideas, themes, or concepts. For instance, while the Harry Potter novels are protected as expressive works, the abstract idea of a wizarding school remains free for public use. This distinction underscores the nuanced nature of subject matter eligibility in IP law.
The recent policy shifts seek to broaden the scope of protected subject matter across diverse domains, including Graphical User Interfaces (GUIs), pharmaceutical drugs, and generative artificial intelligence (Gen AI). This expansion extends across multiple IP regimes, such as patents, copyright, regulatory data protection, and designs. Yet, this broadening is criticized as unwarranted, unsupported by new evidence, and methodologically flawed.
IP laws govern the production and distribution of information goods—intangible knowledge or information embodied in various forms. For example, a patent on the small-molecule drug Risdipalm, used to treat spinal muscular atrophy (SMA), protects the knowledge of the molecule’s therapeutic properties rather than the molecule itself. This distinction is crucial for understanding that IP rights protect intangible information, not physical products or processes.
Not all information goods qualify for exclusionary protection. Copyright law’s protection of expression but not ideas exemplifies this selective eligibility. Expanding subject matter eligibility means more information goods—typically non-rivalrous and non-excludable—would become private property, restricting others’ use. Such state intervention imposes access costs and can reduce competition, raising concerns about optimal policy design.
Information goods are non-excludable by nature; for example, a drug’s chemical compound can be reverse-engineered and reproduced by competitors if not protected by patents. Patents convert these non-excludable goods into excludable ones through state enforcement, granting rights holders the ability to exclude others from manufacturing or using the protected knowledge.
Moreover, information goods are non-rivalrous—one person’s use does not diminish another’s ability to use the same good. Reading a novel does not prevent others from reading it, unlike consuming a physical apple. This non-rivalrous nature challenges the traditional justification for property rights, which is to exclude others to protect one’s own use-value.
Scholars Talha Syed and Oren Bracha highlight that since information use does not conflict, the core rationale for property rights is weakened. State intervention in IP is primarily justified to ensure creators receive fair compensation for their investments, given high upfront costs and negligible copying costs. Exclusion is one mechanism among many, such as state grants or prizes, to achieve this compensation.
Because the marginal cost of producing information is effectively zero, exclusionary IP regimes impose access costs and generate deadweight loss—economic inefficiencies that prevent full utilization of information goods. This is particularly evident in access to medicines, where patented drugs may be priced beyond the reach of many patients, resulting in tangible harm and loss of life.
Despite these significant implications, the current policy expansions lack new empirical evidence to justify them. Instead, they rely on broad claims of protecting innovation, supporting the creator economy, or aligning with international IP standards. These justifications remain vague and unsubstantiated.
In sum, India’s IP policy trajectory towards expanding subject matter eligibility demands rigorous evidence and careful consideration of access and competition impacts. Without such grounding, the risk of unintended consequences—such as restricted access to essential medicines and stifled innovation—remains high. Policymakers are urged to balance the need for creator compensation with the public interest in maintaining open access to information goods.
India’s IP Policy Expansion Lacks Empirical Support, Risks Access and Innovation India’s evolving intellectual property framework is witnessing an expansion in the scope of protected subject matter across patents, copyright, and related laws. However, this broadening lacks empirical justification an... Read the full IIPLA article: https://iipla.org/news/india-s-ip-policy-expansion-lacks-empirical-support-risks-access-and-innovation